2nd KEMRI Annual Scientific & Health Conference (KASH)

In order to view this object you need Flash Player 9+ support!

Get Adobe Flash player

Powered by RS Web Solutions

Wednesday, October 22, 2014
Text Size

Job Opportunities



Course Announcement

course announcement 2014

In the News

director-kemri-visits-nagasaki-university-japan Director, KEMRI, Prof Solomon Mpoke pays a courtesy call on the President of Nagasaki University, Dr Shigeru Katamine at his office on 15th October...
invitation-to-tender-procurement-of-laboratory-equipmentDownload Full Tender Document
equity-bank-partners-with-kemri-in-research-a-mobile-banking-service Equity Bank’s Chief Operating Officer, Dr. Julius Kipng’etich (L) shows the Director, KEMRI, Prof. Solomon Mpoke how the Equity bank mobile banking...
director-kemri-visits-cdc-headquarters-in-atlanta-us  Director, KEMRI, Prof. Solomon Mpoke (second right) pose for a photograph with Ms. Jamie Leiger of CDC Procurement and Grants Office during his...
ethiopia-hosts-the-first-leap-conference  KEMRI’s Senior Marketing Officer, Ms. Doris Night (left) demonstrates how to use the KEMRub hand sanitizer produced by KEMRI to Head DNDi Africa,...

KASH Conference

4th-6th FEBRUARY, 2015

Call for Abstracts

Symposium Application Form

Exhibitor Registration Form

Calendar of Events

October 2014 November 2014
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31


Kemri Welcome trust





Director, KEMRI visits CDC Headquarters in Atlanta, US

DK in Atlanta

Director, KEMRI, Prof. Solomon Mpoke (second right) pose for a photograph with Ms. Jamie Leiger of CDC Procurement and Grants Office during his recent visit to the CDC headquarters in Atlanta, US. Also in the picture is Principle Investigator for the Cooperative Agreement (COAG) Program, Dr. John Vulule and John Ndege, the Chief Operating Officer, COAG.

2nd KEMRI Annual Scientific & Health Conference (KASH)

Theme: Towards A Healthy, Globally Competitive Nation: Vision 2030 Flagships

Dr. Edwin Muinga

Dr. Edwin Muinga Chokwe, HSC,
Chairman, KEMRI Board of Management

Attaining Kenya Vision 2030, the nation's economic blueprint, requires a fresh perspective in the way we perceive research and KEMRI's role in national development. The link between health and poverty is self evident as each impacts the other resulting in a vicious cycle where poor health is both a result and a cause of poverty.

As such the dealing with one without being cognizant of the other only serves to derail the desired impact. Health research should therefore be linked to economic development through the promoting of human and social development, and also more directly through industrialization as we strive to attain a knowledge-economy driven, middle income status by the year 2030. This was reflected in the theme of this year's conference, "Towards a healthy, globally competitive nation: Vision 2030 flagships," which affirms KEMRI's role not just in human and social development but also in the knowledge economy through the innovation of R&D outputs.


Bridging the Gap in Health Research in Africa

This conference therefore serves to showcase excellence in research as the bedrock of this theme. Two major ground breaking research results emanating from research carried out by KEMRI and our collaborators have recently been listed among the top 10 technological breakthroughs of the year by the journal Science. This includes the phase III clinical trial results of the candidate malaria vaccine RTSS, which reported 56 percent and 47 percent efficacy in the prevention of clinical and severe malaria in children respectively. The multicentre trial was conducted in 11 sites across 7 African countries, in which KEMRI played a significant role, having hosted 3 of the 11 sites at the KEMRI/CDC Research and Public Health Collaboration in Kisumu, the KEMRI-Wellcome-Trust Research Programme in Kilifi and the KEMRI/Walter Reed Project site at Kombewa.

The other major breakthrough in which KEMRI has been involved is the HIV Prevention Trials Network (HPTN) multinational clinical study, HPTN 052, which demonstrated reduction of HIV transmission in serodiscordant couples through the early treatment of HIV using ARVs by an astounding 96 percent. Both studies have served to inform policy and revitalize the fight against the scourge of these diseases not just in Kenya but the world over.

Additionally, KEMRI remains committed to the national and WHO roadmaps for the control and elimination of 10 of the 17 neglected tropical diseases by the year 2020. Significant advances have been made on this front with results emanating from DNDi, of which KEMRI is both a founding member and partner through CCR, have informed the WHO recommendation of paramomycin-sodium

 stibogluconate (PM-SSG) drug combination as the first line treatment for visceral leishmaniasis in east Africa.

Further to the excellent research coming out of KEMRI, the conference also highlighted special areas of public health interest through dedicated symposia focusing on road safety, neglected tropical diseases, bioethics, health systems and social sciences research, all addressing aspects of health and human/social development.

For the first time, a symposium on pharmaceutical and health products innovation, focusing solely on the business of the science addressed aspects of knowledge economy and industrialization.

DKDr. Solomon Mpoke, PhD, MBS,
Director, KEMRI


Ebola Advisory


 A Scientist working in the Biosafety Level 3 Laboratory, one of the specialized laboratories in KEMRI with capability of screening for Suspected Ebola Viral Disease (EVD) Sample and other Viral hemorrhagic fevers (VHFs).


What's New

food borne workshop

African research scientists benefited from a Global Foodborne Infections Network Workshop on Integrated Surveillance of Foodborne Diseases and Antimicrobial Resistance, held at the Kenya Medical Research Institute (KEMRI) from August 18th-22nd, 2014.

Read More . . .


Coming Up



Read More . . .




We have 132 guests online


"To be a leading centre of excellence in research for human health."


"To improve human health and quality of life through research, capacity building, innovation and service delivery."




"In Search of Better Health"
towards the realization of our Vision





Do you have a complaint?
Click Here